Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check46 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check67 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check82 days agoChange DetectedThe AREDS2 Website has been added.SummaryDifference0.1%
Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.